March 25, 2019
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Jeffrey Gabor
Re: Precision BioSciences, Inc.
Registration Statement on Form S-1
File No. 333-230034
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between March 18, 2019 and the date hereof, approximately 1,907 copies of the Preliminary Prospectus dated March 18, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on March 27, 2019 or as soon thereafter as practicable.
[Signature page follows]
| Very truly yours, | ||
| J.P. Morgan Securities LLC | ||
| Goldman Sachs & Co. LLC | ||
| Jefferies LLC | ||
| Barclays Capital Inc. | ||
| As representatives of the Underwriters | ||
| J.P. Morgan Securities LLC | ||
| By: | /s/ David Ke | |
| Name: David Ke | ||
| Title: Executive Director | ||
| Goldman Sachs & Co. LLC | ||
| By: | /s/ Lyla Bibi | |
| Name: Lyla Bibi | ||
| Title: Managing Director | ||
| Jefferies LLC | ||
| By: | /s/ Charlie Glazer | |
| Name: Charlie Glazer | ||
| Title: Managing Director | ||
| Barclays Capital Inc. | ||
| By: | /s/ Victoria Hale | |
| Name: Victoria Hale | ||
| Title: Vice President | ||
[Signature Page to Underwriters Acceleration Letter]